We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-0.96%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$273M
AUM Growth
-$56.5M
Cap. Flow
-$54.5M
Cap. Flow %
-20%
Top 10 Hldgs %
37.85%
Holding
118
New
32
Increased
13
Reduced
18
Closed
50

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$9.34M
2
ABBV icon
AbbVie
ABBV
+$9.18M
3
HOLX
Hologic
HOLX
+$8.27M
4
BCR
CR Bard Inc.
BCR
+$7.93M
5
IEV icon
iShares Europe ETF
IEV
+$7.1M

Top Sells

Rank Stock Value
1
SYK icon
Stryker
SYK
+$9.7M
2
ABT icon
Abbott
ABT
+$8.67M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$8.13M
4
LLY icon
Eli Lilly
LLY
+$7.49M
5
NVS icon
Novartis
NVS
+$7.27M

Sector Composition

Rank Sector Weight
1 Healthcare 52.58%
2 Industrials 3.66%
3 Financials 1.77%
4 Technology 1.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BSX icon
26
CALL
Boston Scientific
BSX
$73.1B
$4.33M 1.59%
+200,000
New +$4.36M
SIEN
27
DELISTED
Sientra, Inc.
SIEN
$4.26M 1.56%
50,000
-5,266
-10% -$438K
TMO icon
28
PUT
Thermo Fisher Scientific
TMO
$222B
$4.23M 1.55%
+30,000
New +$4.42M
GKOS icon
29
Glaukos
GKOS
$10.7B
$3.77M 1.38%
+109,903
New +$3.76M
MEDP icon
30
Medpace
MEDP
$16.8B
$3.7M 1.36%
102,507
-55,921
-35% -$1.86M
GWPH
31
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$3.6M 1.32%
32,250
+4,395
+16% +$529K
NSTG
32
DELISTED
NanoString Technologies, Inc.
NSTG
$3.6M 1.32%
161,311
+64,325
+66% +$1.38M
NXGN
33
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$3.51M 1.29%
+266,617
New +$3.42M
FXH icon
34
PUT
First Trust Health Care AlphaDEX Fund
FXH
$1.12B
$3.44M 1.26%
60,000
-90,000
-60% -$5.21M
CFMS
35
DELISTED
Conformis, Inc. Common Stock
CFMS
$3.4M 1.25%
+16,769
New +$3.71M
ICUI icon
36
ICU Medical
ICUI
$4.56B
$3.31M 1.22%
+22,500
New +$3.26M
WMGI
37
DELISTED
Wright Medical Group Inc
WMGI
$3.22M 1.18%
140,000
-15,000
-10% -$349K
IVC
38
DELISTED
Invacare Corporation
IVC
$2.92M 1.07%
223,439
-86,561
-28% -$996K
ELGX
39
DELISTED
Endologix Inc
ELGX
$2.86M 1.05%
+50,000
New +$4.58M
LPNT
40
PUT
DELISTED
LifePoint Health, Inc.
LPNT
$2.84M 1.04%
+50,000
New +$2.89M
XRAY icon
41
Dentsply Sirona
XRAY
$2.32B
$2.74M 1.01%
+47,500
New +$2.81M
AVXS
42
DELISTED
AveXis, Inc. Common Stock
AVXS
$2.5M 0.92%
52,375
-58,625
-53% -$3.13M
EWA icon
43
CALL
iShares MSCI Australia ETF
EWA
$1.47B
$2.02M 0.74%
+100,000
New +$2.06M
NXGN
44
CALL
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$1.91M 0.7%
+145,300
New +$1.86M
NDRM
45
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$1.78M 0.65%
80,183
+40,000
+100% +$748K
ANIP icon
46
ANI Pharmaceuticals
ANIP
$1.74B
$1.59M 0.58%
+26,250
New +$1.61M
FOMX
47
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1.52M 0.56%
137,000
– –
AGN
48
DELISTED
Allergan plc
AGN
$1.41M 0.52%
6,700
-4,050
-38% -$839K
SUPN icon
49
Supernus Pharmaceuticals
SUPN
$2.74B
$1.39M 0.51%
+55,000
New +$1.23M
ARRY
50
DELISTED
Array Biopharma Inc
ARRY
$1.38M 0.51%
157,360
+127,360
+425% +$937K
1
2
3 4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SR
Swiss Re Zurich, Switzerland $16.4M AUM
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return

Pura Vida Investments's Q4 2016 Portfolio in Review

As of Q4 2016, Pura Vida Investments held 118 positions worth $273M, down 17% from $329M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Pura Vida Investments withdrew a net $54.5M in Q4 2016, closing 50 positions and reducing 18 holdings. Its most notable exit was Stryker, an estimated $9.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 62% a quarter earlier, followed by Industrials and Financials.

Against the trend, Pura Vida Investments opened a new position in UnitedHealth worth $10M.

  • Pura Vida Investments's largest Q4 2016 buy was UnitedHealth: 62,500 shares worth $10M.
  • Pura Vida Investments added most to Athenahealth, Inc. in Q4 2016, an estimated $4.3M increase.
  • Pura Vida Investments's biggest Q4 2016 reduction was Aetna Inc, cutting an estimated $3.63M.
  • Pura Vida Investments fully exited Stryker in Q4 2016, selling an estimated $9.7M.
  • Pura Vida Investments's ten largest holdings make up 38% of its $273M portfolio in Q4 2016.
  • Pura Vida Investments opened 32 new positions and closed 50 in Q4 2016.
  • Pura Vida Investments's portfolio value fell 17% quarter-over-quarter to $273M.

Based on Pura Vida Investments's 13F filing for Q4 2016, filed 14 Feb 2017.